Skip NavigationSkip to Content
Return Return to Search Results

Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine

  1. Author:
    Mikszta, J. A.
    Dekker, J. P.
    Harvey, N. G.
    Dean, C. H.
    Brittingham, J. M.
    Huang, J.
    Sullivan, V. J.
    Dyas, B.
    Roy, C. J.
    Ulrich, R. G.

  2. Author Address

    BD Technol, Res Triangle Pk, NC 27709 USA. USA, Med Res Inst Infect Dis, Frederick, MD 21702 USA.;Mikszta, JA, BD Technol, 21 Davis Dr, Res Triangle Pk, NC 27709 USA.;john_mikszta@bd.com
    1. Year: 2006
    2. Date: Dec
  2. Journal: Infection and Immunity
    1. 74
    2. 12
    3. Pages: 6806-6810
  4. Type of Article: Article
  5. ISSN: 0019-9567
  1. Abstract:

    The recombinant protective antigen (rPA) of Bacillus anthracis is a promising anthrax vaccine. We compared serum immunoglobulin G levels and toxin-neutralizing antibody titers in rabbits following delivery of various doses of vaccine by microneedle-based intradermal (i.d.) delivery or intramuscular (i.m.) injection using conventional needles. Intradermal delivery required less antigen to induce levels of antibody similar to those produced via i.m. injection during the first 2 weeks following primary and booster inoculation. This dose-sparing effect was less evident at the later stages of the immune response. Rabbits immunized i.d. with 10 mu g of rPA displayed 100% protection from aerosol spore challenge, while i.m. injection of the same dose provided slightly lower protection (71%). Groups immunized with lower antigen doses were partially protected (13 to 29%) regardless of the mode of administration. Overall, our results suggest rPA formulated with aluminum adjuvant and administered to the skin by a microneedle-based device is as efficacious as i.m. vaccination.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1128/iai.01210-06
  3. View record in Web of Science®
  4. WOS: 000242308100031

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel